DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 -3.91 -0.08%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Stock Market News for June 15, 2015 - Market News

Why I'm Shorting Biotech

Biotech has been crushing the broader markets for several years running at this point. However, this amazing run might be about to come to a screeching halt, making now a good time to short biotech.

VHT, PFE, BMY, LLY: Large Inflows Detected at ETF

Cancer Stocks: 2 to Sell, 1 to Buy

Advaxis, Ariad Pharmaceuticals, and Exelixis Inc. are three cancer fight companies that could generate out-sized gains for investors. A deeper look, however, suggests that only one company is a compelling buy right now.

Cancer Stocks: 2 to Sell, 1 to Buy

Advaxis, Ariad Pharmaceuticals, and Exelixis Inc. are three cancer fight companies that could generate out-sized gains for investors. A deeper look, however, suggests that only one company is a compelling buy right now.

Short Sellers Back Off Big Pharma

Bristol-Myers Squibb's (BMY) Management Presents at Goldman Sachs 36th Annual Global Health Care - C

Bristol-Myers Squibb's (BMY) Management Presents at Goldman Sachs 36th Annual Global Health Care - Conference Call Transcript

Gilead: So Much More Than HCV

As Cancer Immunotherapy Turns 125, WBB Securities’ Steve Brozak Ponders What Investors Can Expect fr

As Cancer Immunotherapy Turns 125, WBB Securities’ Steve Brozak Ponders What Investors Can Expect from Biotech

Merck’s New Filing For Keytruda Is A Meaningful Move

See More Articles...